Growth inhibition of Crithidia fasciculata by serotoninergic and adrenergic drugs.
D000628:Aminophylline / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D003533:Cyproheptadine / Q000494:pharmacology*; D003891:Desipramine / Q000494:pharmacology*; D056890:Eukaryota / Q000187:drug effects / Q000254:growth & development*; D006834:Hydrazines / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D007490:Iproniazid / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013768:Tetrahymena / Q000187:drug effects / Q000254:growth & development; D014191:Tranylcypromine / Q000494:pharmacology
D006834:Hydrazines; D010643:Phenoxybenzamine; D000628:Aminophylline; D003533:Cyproheptadine; D014191:Tranylcypromine; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D007490:Iproniazid; D011299:Prenylamine; D007545:Isoproterenol; D007099:Imipramine; D003891:Desipramine